Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy BiondVax Pharmaceuticals stock | $3.03
Learn how to easily invest in BiondVax Pharmaceuticals stock.
BiondVax Pharmaceuticals Ltd is a biotechnology business based in the US. BiondVax Pharmaceuticals shares (BVXV) are listed on the NASDAQ and all prices are listed in US Dollars. BiondVax Pharmaceuticals employs 21 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in BiondVax Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BVXV – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
BiondVax Pharmaceuticals stock price (NASDAQ: BVXV)Use our graph to track the performance of BVXV stocks over time.
BiondVax Pharmaceuticals shares at a glance
|Latest market close||$3.03|
|52-week range||$2.28 - $43.57|
|50-day moving average||$2.91|
|200-day moving average||$3.62|
|Wall St. target price||$81.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.30|
Buy BiondVax Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy BiondVax Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
BiondVax Pharmaceuticals price performance over time
|1 week (2021-07-24)||N/A|
|1 month (2021-07-02)||8.21%|
|3 months (2021-05-04)||0.33%|
|6 months (2021-01-31)||N/A|
|1 year (2020-07-31)||N/A|
|2 years (2019-07-31)||N/A|
|3 years (2018-07-31)||N/A|
|5 years (2016-07-31)||N/A|
BiondVax Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||5.31%|
|Return on equity TTM||0%|
|Market capitalisation||$41.8 million|
TTM: trailing 12 months
Shorting BiondVax Pharmaceuticals shares
There are currently 402,553 BiondVax Pharmaceuticals shares held short by investors – that's known as BiondVax Pharmaceuticals's "short interest". This figure is 9.7% up from 366,965 last month.
There are a few different ways that this level of interest in shorting BiondVax Pharmaceuticals shares can be evaluated.
BiondVax Pharmaceuticals's "short interest ratio" (SIR)
BiondVax Pharmaceuticals's "short interest ratio" (SIR) is the quantity of BiondVax Pharmaceuticals shares currently shorted divided by the average quantity of BiondVax Pharmaceuticals shares traded daily (recently around 64927.903225806). BiondVax Pharmaceuticals's SIR currently stands at 6.2. In other words for every 100,000 BiondVax Pharmaceuticals shares traded daily on the market, roughly 6200 shares are currently held short.
However BiondVax Pharmaceuticals's short interest can also be evaluated against the total number of BiondVax Pharmaceuticals shares, or, against the total number of tradable BiondVax Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BiondVax Pharmaceuticals's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 BiondVax Pharmaceuticals shares in existence, roughly 30 shares are currently held short) or 0.0288% of the tradable shares (for every 100,000 tradable BiondVax Pharmaceuticals shares, roughly 29 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against BiondVax Pharmaceuticals.
Find out more about how you can short BiondVax Pharmaceuticals stock.
BiondVax Pharmaceuticals share dividends
We're not expecting BiondVax Pharmaceuticals to pay a dividend over the next 12 months.
BiondVax Pharmaceuticals share price volatility
Over the last 12 months, BiondVax Pharmaceuticals's shares have ranged in value from as little as $2.28 up to $43.5685. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BiondVax Pharmaceuticals's is 2.2508. This would suggest that BiondVax Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
BiondVax Pharmaceuticals overview
BiondVax Pharmaceuticals Ltd. , a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and related illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel. .
Stocks similar to BiondVax Pharmaceuticals
BiondVax Pharmaceuticals in the news
62 Biggest Movers From Yesterday
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
Stocks That Hit 52-Week Lows On Tuesday
Frequently asked questionsWhat percentage of BiondVax Pharmaceuticals is owned by insiders or institutions?
Currently 29.821% of BiondVax Pharmaceuticals shares are held by insiders and 2.041% by institutions. How many people work for BiondVax Pharmaceuticals?
Latest data suggests 21 work at BiondVax Pharmaceuticals. When does the fiscal year end for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals's fiscal year ends in December. Where is BiondVax Pharmaceuticals based?
BiondVax Pharmaceuticals's address is: Jerusalem BioPark Building, Jerusalem, Israel, 7414002 What is BiondVax Pharmaceuticals's ISIN number?
BiondVax Pharmaceuticals's international securities identification number is: US09073Q1058 What is BiondVax Pharmaceuticals's CUSIP number?
BiondVax Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 09073Q105
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert